FORM 10-K HEMISPHERX BIOPHARMA, INC.

Company

AIM ImmunoTech Inc.

Filed

March 29, 2000

Period of Report

December 31, 1999

Accession Number

0000946644-00-000002

A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →